Evidence map›Paper›PMID 32293748›Full record

ArticleThe EMBO journal2020

Toxoplasma GRA15 limits parasite growth in IFNγ-activated fibroblasts through TRAF ubiquitin ligases.

Debanjan Mukhopadhyay, Lamba Omar Sangaré, Laurence Braun, Mohamed-Ali Hakimi, Jeroen Pj Saeij

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 40 citations in OpenAlex.

  1. A Suite of EightbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Dense granule proteins: key mediators ofFrontiers in medicine · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Susceptibility ofmBio · 2024
    Article
  10. Article
  11. Review
  12. A Combination of Four Nuclear Targeted Effectors ProtectsbioRxiv : the preprint server for biology · 2023
    Article
  13. p97/VCP targetsmSphere · 2023
    Article
  14. Host E3 ubiquitin ligase ITCH mediatesbioRxiv : the preprint server for biology · 2023
    Article
  15. ThemSphere · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Debanjan MukhopadhyayDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Lamba Omar SangaréDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Laurence BraunInstitute for Advanced Biosciences, Team Host-Pathogen Interactions and Immunity to Infection, INSERM U1209, CNRS, UMR5309, Université Grenoble Alpes, Grenoble, France.
Mohamed-Ali HakimiInstitute for Advanced Biosciences, Team Host-Pathogen Interactions and Immunity to Infection, INSERM U1209, CNRS, UMR5309, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-2547-8233
Jeroen Pj SaeijDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.ORCID 0000-0003-0289-7109
University of California, Davis · USCentre National de la Recherche Scientifique · FR

Funding

Toxoplasma strain-specific modulation of mouse immune cellsR01AI080621 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SAEIJ, JEROEN · 2009 to 2018
$3.6M
American Heart Association (AHA) 18POST34030036NIAID NIH HHS R01 AI080621
6 · The paper itself

Abstract

The protozoan parasite Toxoplasma gondii lives inside a vacuole in the host cytosol where it is protected from host cytoplasmic innate immune responses. However, IFNγ-dependent cell-autonomous immunity can destroy the vacuole and the parasite inside. Toxoplasma strain differences in susceptibility to human IFNγ exist, but the Toxoplasma effector(s) that determine these differences are unknown. We show that in human primary fibroblasts, the polymorphic Toxoplasma-secreted effector GRA15 mediates the recruitment of ubiquitin ligases, including TRAF2 and TRAF6, to the vacuole membrane, which enhances recruitment of ubiquitin receptors (p62/NDP52) and ubiquitin-like molecules (LC3B, GABARAP). This ultimately leads to lysosomal degradation of the vacuole. In murine fibroblasts, GRA15-mediated TRAF6 recruitment mediates the recruitment of immunity-related GTPases and destruction of the vacuole. Thus, we have identified how the Toxoplasma effector GRA15 affects cell-autonomous immunity in human and murine cells.

Indexed as

AnimalsCells, CulturedFibroblastsForeskinGene Expression RegulationHumansInterferon-gammaIntracellular Signaling Peptides and ProteinsMaleMiceProtozoan ProteinsSignal TransductionToxoplasmaUbiquitin-Protein LigasesVacuolesInterferon-gammaIntracellular Signaling Peptides and ProteinsProtozoan ProteinsTifab protein, humanUbiquitin-Protein LigasesGRA15IFNγp62ToxoplasmaTRAF6

Identifiers

PMID32293748
PMCPMC7232000
OpenAlexW3015902389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.